SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GZMO -- Ignore unavailable to you. Want to Upgrade?

To: Extra Pale who wrote (403)10/23/2001 5:24:25 PM
From: keokalani'nui  Read Replies (1) | Respond to of 438
 
Pardon my rant.

Right, GZMO is going to acquire a late stage drug AND cash; like all of a sudden they are going to become by transaction what they haven't accomplished by execution? I heard that new strategy too and have had flu-like symptoms ever since.

All my ideas for the company involve hanging a 'for sale' sign around its neck. But I don't think that's what Gail Gordon Gecko Madeiras has in mind.

They seem to chronically over estimate the value of their own technology. I'm equally mad at myself. I think I made a little mistake here about a year ago.

Wilder



To: Extra Pale who wrote (403)10/29/2001 11:56:54 AM
From: Extra Pale  Respond to of 438
 
How about this for a merger: genz buys ttp (mkt cap $175m) placing cash, vaccine and cancer assets with gzmo; and putting pharma partnered Iloperidone and Spheramine (parkinsons treatment) with genz general (which discontinued its Neurocell cell implant program aimed at Parkinsons).


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News